BHARAT Probability Of Bankruptcy

BHARAT IMMUNOLOGICALS Probability Of Bankruptcy is used to show its chance of financial distress over the next two years of operations under current economic and market conditions. BHARAT IMMUNOLOGICALS Probability Of Bankruptcy is determined by interpolating and adjusting BHARAT Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the BHARAT balance sheet as well as cash flow and income statements available from the company's most recent filings. Check out Trending Equities.

Search Probability Of Bankruptcy 

 
Refresh

BHARAT Probability Of Bankruptcy Analysis

BHARAT IMMUNOLOGICALS's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
More About Probability Of Bankruptcy | All Equity Analysis

Current BHARAT IMMUNOLOGICALS Probability Of Bankruptcy

    
  49%  
Most of BHARAT IMMUNOLOGICALS's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BHARAT IMMUNOLOGICALS BIOLOG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of BHARAT IMMUNOLOGICALS probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting BHARAT IMMUNOLOGICALS odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of BHARAT IMMUNOLOGICALS BIOLOG financial health.
Please note, there is a significant difference between BHARAT IMMUNOLOGICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine BHARAT IMMUNOLOGICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BHARAT IMMUNOLOGICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Compare to competition

Based on the latest financial disclosure, BHARAT IMMUNOLOGICALS BIOLOG has a Probability Of Bankruptcy of 49.0%. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The probability of bankruptcy for all India stocks is notably lower than that of the firm.
  Chance Of Financial Distress
Less than 49
BHARAT IMMUNOLOGICALS BIOLOG has less than 49 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for BHARAT IMMUNOLOGICALS stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

BHARAT Fundamentals

BHARAT IMMUNOLOGICALS Investors Sentiment

The influence of BHARAT IMMUNOLOGICALS's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BHARAT. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - BIBCL

BHARAT IMMUNOLOGICALS Investor Sentiment

Most of Macroaxis users are currently bullish on BHARAT IMMUNOLOGICALS BIOLOG. What is your opinion about investing in BHARAT IMMUNOLOGICALS BIOLOG? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with BHARAT IMMUNOLOGICALS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BHARAT IMMUNOLOGICALS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BHARAT IMMUNOLOGICALS will appreciate offsetting losses from the drop in the long position's value.

BHARAT IMMUNOLOGICALS Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Twitter and Weibo Corp Ads. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Note that the BHARAT IMMUNOLOGICALS information on this page should be used as a complementary analysis to other BHARAT IMMUNOLOGICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Tools for BHARAT IMMUNOLOGICALS Stock

When running BHARAT IMMUNOLOGICALS price analysis, check to measure BHARAT IMMUNOLOGICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BHARAT IMMUNOLOGICALS is operating at the current time. Most of BHARAT IMMUNOLOGICALS's value examination focuses on studying past and present price action to predict the probability of BHARAT IMMUNOLOGICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BHARAT IMMUNOLOGICALS's price. Additionally, you may evaluate how the addition of BHARAT IMMUNOLOGICALS to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go